Kaiser Appeals Abbott MDL Antitrust Patent Case

Law360, New York (November 4, 2009, 12:35 PM EST) -- Kaiser Foundation Health Plan Inc. is appealing a judgment in favor of Abbott Laboratories in a patent and antitrust dispute involving multidistrict litigation over the hypertension drug Hytrin.

The health plan filed notice on Tuesday it would appeal the decision by a U.S. District Court for the Central District of California to the U.S. Court of Appeals for the Ninth Circuit.

Kaiser charged Abbott with violating two sections of the Sherman Antitrust Act and with fraudulent conduct before the U.S. Patent and Trademark Office concerning its...
To view the full article, register now.